Therapeutic Asset Ratings

472 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Irinotecan Medulloblastoma	Pfizer	P2	BB (64)
Ponsegromab Loss of Appetite	Pfizer	P2	BB (64)
PREDNISONE TABLETS Lung Cancer	Pfizer	P4	B (63)
(+)-VINCRISTINE Solid Tumor	Pfizer	P4	B (63)
FLUOROURACILUM Triple Negative Breast Cancer	Pfizer	P3	B (63)
Vepdegestrant Breast Cancer	Pfizer	P3	B (63)
(+)-VINCRISTINE Colorectal Adenocarcinoma	Pfizer	P3	B (63)
(+)-VINCRISTINE Intestinal Neoplasms	Pfizer	P3	B (63)
Irinotecan Melanoma	Pfizer	P2	B (63)
(+)-VINCRISTINE Melanoma	Pfizer	P2	B (63)
Cyclophosphamide Lung Diseases	Pfizer	P3	B (62)
pf-06838435 Hemophilia B	Pfizer	P3	B (62)
(+)-VINCRISTINE Gastrointestinal Neoplasms	Pfizer	P3	B (62)
Carfilzomib Stage III Adult Diffuse Large Cell Lymphoma	Pfizer	P1/2	B (62)
Calcium folinate pentahydrate Triple Negative Breast Cancer	Pfizer	P3	B (61)
Cetuximab Breast Cancer	Pfizer	P2	B (61)
Eloxatin Melanoma	Pfizer	P2	B (61)
Samuraciclib Metastatic Breast Cancer	Pfizer	P2	B (61)
Axitinib Urothelial Cancer	Pfizer	P3	B (60)
Calcium folinate pentahydrate Breast Cancer	Pfizer	P3	B (60)
Ceritinib Non-Small Cell Lung Cancer	Pfizer	P3	B (60)
Cetuximab Triple Negative Breast Cancer	Pfizer	P3	B (60)
Cmp 001 Advanced Malignancies	Pfizer	P3	B (60)
IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER Hemophilia B	Pfizer	P3	B (60)
Irinotecan Colonic Diseases	Pfizer	P3	B (60)

Showing 51 to 75 of 472 assets